1. Home
  2. MCHX vs ELUT Comparison

MCHX vs ELUT Comparison

Compare MCHX & ELUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MCHX
  • ELUT
  • Stock Information
  • Founded
  • MCHX 2003
  • ELUT 2015
  • Country
  • MCHX United States
  • ELUT United States
  • Employees
  • MCHX N/A
  • ELUT N/A
  • Industry
  • MCHX Business Services
  • ELUT Medical Specialities
  • Sector
  • MCHX Consumer Discretionary
  • ELUT Health Care
  • Exchange
  • MCHX Nasdaq
  • ELUT Nasdaq
  • Market Cap
  • MCHX 84.3M
  • ELUT 79.7M
  • IPO Year
  • MCHX 2004
  • ELUT 2020
  • Fundamental
  • Price
  • MCHX $1.96
  • ELUT $0.89
  • Analyst Decision
  • MCHX
  • ELUT Strong Buy
  • Analyst Count
  • MCHX 0
  • ELUT 2
  • Target Price
  • MCHX N/A
  • ELUT $7.00
  • AVG Volume (30 Days)
  • MCHX 24.6K
  • ELUT 310.7K
  • Earning Date
  • MCHX 10-30-2025
  • ELUT 11-13-2025
  • Dividend Yield
  • MCHX N/A
  • ELUT N/A
  • EPS Growth
  • MCHX N/A
  • ELUT N/A
  • EPS
  • MCHX N/A
  • ELUT N/A
  • Revenue
  • MCHX $47,534,000.00
  • ELUT $23,683,000.00
  • Revenue This Year
  • MCHX N/A
  • ELUT $19.68
  • Revenue Next Year
  • MCHX $7.56
  • ELUT $70.28
  • P/E Ratio
  • MCHX N/A
  • ELUT N/A
  • Revenue Growth
  • MCHX N/A
  • ELUT N/A
  • 52 Week Low
  • MCHX $1.26
  • ELUT $0.85
  • 52 Week High
  • MCHX $2.40
  • ELUT $5.12
  • Technical
  • Relative Strength Index (RSI)
  • MCHX 50.62
  • ELUT 23.41
  • Support Level
  • MCHX $1.65
  • ELUT $0.86
  • Resistance Level
  • MCHX $1.98
  • ELUT $1.22
  • Average True Range (ATR)
  • MCHX 0.09
  • ELUT 0.06
  • MACD
  • MCHX 0.00
  • ELUT 0.02
  • Stochastic Oscillator
  • MCHX 72.57
  • ELUT 13.19

About MCHX Marchex Inc. Class B

Marchex Inc is a conversational analytics and solutions company that helps businesses connect, drive, measure, convert callers into customers, and connect the voice of the customer to their business. It delivers data insights and incorporates artificial intelligence (AI)-powered functionality that drives insights and solutions to help companies find, engage, and support their customers across voice and text-based communication channels. The group enables sales and marketing teams to deliver the buying experiences that today's customers expect. The company generates the majority of its revenues from core analytics and solutions services. The company operates in the United States, Canada, and other countries.

About ELUT Elutia Inc.

Elutia Inc Formerly Aziyo Biologics Inc is a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, concentrating on patients receiving implantable medical devices. The company's segments include Device Protection, Women's Health and Cardiovascular. It generates maximum revenue from the Women's Health segment. The products of the company are targeted to address unmet clinical needs with the goal of promoting healthy tissue formation and avoiding complications associated with medical device implants, such as scar-tissue formation, capsular contraction, erosion, migration, non-union of implants and implant rejection.

Share on Social Networks: